Introduction
Turner's syndrome (TS) results from absence of one X chromosome in women (X monosomy). Its prevalence is estimated to be 1 in 3000-5000 live female births. Between 28% and 67% of TS subjects have a mosaic pattern (TSm) where some cells have a normal chromosomal set and others have only one normal X chromosome. The phenotype, not precisely related to the degree of monosomy, includes short stature, webbing of the neck, gonadal dysgenesis and coarctation of the aorta among other vascular abnormalities.
The full neurological spectrum can include mental retardation, psychosis and neuropsychological disorders. 1 The literature contains very few cases of TS patients suffering from epilepsy, 2,3 most of them presenting with significant cortical malformation. 4, 5 Recently, greater attention has been directed to the role of the X chromosome in brain development. Several studies have focused on the particular profile of cognitive functions as well as structural and metabolic brain abnormalities in TS. [6] [7] [8] [9] [10] [11] [12] [13] Studies on TS patients consistently point to structural and metabolic brain abnormalities that also affect the temporal lobe; however, to the best of our knowledge, no case of temporal lobe epilepsy without overt MRI lesion has been described.
Here, we report on a patient with late-onset intractable bilateral non-lesional temporal lobe epilepsy and X chromosome mosaic monosomy. Summary Turner's syndrome (TS), resulting from deletion of one X chromosome in women, is associated with cerebral development abnormalities, particularly in the temporal lobes. Symptomatic epilepsy is described only in cases with extensive malformations. Here, we report the first case of bilateral temporal epilepsy without macroscopic cerebral malformation in a woman with TS mosaicism. Bitemporal dysfunction was confirmed by the ictal and interictal EEG, PET, MR-spectroscopy and the neuropsychological examination, other causes than TS mosaicism were excluded. In rare cases, TS mosaicism may underlie non-lesional temporal lobe epilepsy, probably in relation to microanatomic structural and functional cerebral abnormalities. Further studies are needed to determine the frequency of this association. # 2006 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
In November 2005, a 37-year-old woman was referred for presurgical investigation of drug-resistant temporal lobe epilepsy. Complex partial seizures with thoracic pressure, hypersalivation, chewing, manual automatisms and non-lateralized dystonic posture followed by generalized tonicclonic seizures and ictal amnesia had started at the age of 30 and occurred once per week with nocturnal predominance. The disease had no catamenial periodicity and could not be controlled by phenobarbital, lamotrigine, valproate, topiramate or oxcarbazepine, either alone or in combination. Apart from migraine without aura since her teens, the personal history was unrevealing. The family history revealed a healthy monozygotic twin sister living abroad who had children. The patient herself reported regular menstrual cycles in the past since the age of 15. She has three healthy sons in their teens and had had two other premature children who had died in the neonatal period. At admission, she was carrying a progesterone-coated intra-uterine device with interruption of menstrual cycle for 2 years. The patient's neurological examination was normal except for absence of achillean deep tendon reflexes. She is of normal height (162 cm) with no dysmorphic features and normal development of breasts and external genitalia. The neuropsychological and psychiatric examination with a translator disclosed significant language dysfunction and difficulties in verbal and non-verbal memory as well as executive functions in the presence of a slight depressive disorder. Full IQ testing could not be carried out, given that test material was not available in her language but the patient did not appear retarded and had attended a normal school in her home country.
The interictal EEG showed very active bilateral anterior temporal epileptogenic activity and slowing. Six complex partial seizures (loss of consciousness, chewing, manual automatisms and arm dystonic posture with or without secondary generalized seizure) were recorded, originating more often from the left (4/6) than the right (2/6) anterior temporal lobe (Fig. 1a and b) . High resolution 3T MRI showed no structural abnormality. Single voxel MR spectroscopy (MRS) revealed a diffuse bilateral temporal decrease of the N-acetyl-aspartate/choline ratio affecting both the lateral temporal neocortices and the hippocampi. Concordant with the EEG and MRS finding, interictal PET imaging suggested a bilateral anterior temporal hypometabolism (Fig. 1c) .
In the context of this intractable late-onset nonlesional epilepsy affecting both temporal lobes, an extensive work-up was carried out, including genetic screening for mutation of mitochondrial DNA which comprises also a chromosomal evaluation. Blood tests showed normal blood cell counts, corpuscular volume, ESR, glucose, electrolytes, pyruvate, lactate, creatinine, hepatic enzymes, thyroid function and serum immunoglobulins. There was a moderate hyperammoniemia (103 mmol/l, normal <35) when still under treatment of topiramate and valproate. Vitamin levels were normal except for a slightly diminished cyanocobalamine (118 pmol/l, normal 135-700). There was an unspecific elevation of anti-nuclear antibodies (immunofluorescence titer 320) but rheumatoid factor, anti-nuclear antibodies, anti-nucleoprotein and ANCA were negative. Antithyroid, anti-parietal cell, anti-intrinsic factor, anti-glutamic acid decarboxylase (GAD) and paraneoplastic antibodies were also negative. Hormonal levels including FSH, LH, prolactin, estradiol, progesterone, DHEA, total testosterone, androstenedione were normal. Caryotype analysis revealed a cell line 45, XX in 12% of analysed cells, indicating a mosaic X monosomy. Research for frequent mitochondrial mutations for MERFF and MELAS (3243A > G, 3271T > C, 8344A > G, 8356T > C) was negative. A lumbar puncture showed normal protein and cell counts and absence of oligoclonal bands. Pelvic ultrasound was normal.
In order to rule out iatrogenic encephalopathy in the context of a topiramate medication, this drug was slowly removed. Five months later she was on monotherapy of oxcarbazepine (1500 mg/d). Serum ammonium returned to normal levels. After cessation of topiramate, the seizure frequency slightly diminished to 3 per month. The neuropsychological follow-up showed a clear improvement in language and executive functions. There was no apraxia or agnosia indicative of a parietal dysfunction. A second MRS, performed 4 months after the first one, showed persistent decrease of the N-acetyl-aspartate/cholin ratio in both hippocampi and temporal neocortex, indicating a stable dysfunction.
Discussion
To the best of our knowledge, this is the first published case of TSm associated with non-lesional bilateral temporal lobe epilepsy. Even though the amount of monosomic blood cells is low (12%), the two conditions may be causally related, for the reasons we will outline below.
The X chromosome is strongly implicated in cerebral development. X-linked cerebral malformation syndromes include periventricular heterotopia, polymicrogyria and lissencephaly. TS-linked malformations include bilateral perisylvian atrophy, 4 and extensive polymicrogyria. 5 Rare autopsy descriptions have disclosed mild cortical dysplasia with subcortical heterotopia. 14, 15 Volumetric MRI studies consistently report global and local volume differences in TS subjects compared to normal subjects. Differences were noted in the gray or white matter of the temporal lobes, 6, 7, 9, 12 as well as the amygdalo-hippocampal structures, 8, 10 in a symmetric or asymmetric pattern. TSm patients have a temporal lobe volume between that of normal subjects and full TS patients. 10 These observations point to an abnormal cellular density and connectivity in the mesial and lateral aspects of temporal lobes in TS and probably also TSm subjects. The impact of an abnormal X chromosome is further exemplified by MRI studies in patients with other X chromosome syndromes. Patients with premutations of fragile-X syndrome showed an increased volume of the amygdalo-hippocampal structures, 16 while subjects with Klinefelter syndrome (47, XXY) showed a reduction in temporal grey matter, 17 thus underlining the major impact of the X chromosome on the development of temporal lobe structures.
MR-spectroscopy is an established technique to reveal subtle structural abnormalities in patients with MRI-negative temporal lobe epilepsy. 18 Bilateral low N-acetyl-aspartate-related metabolic ratios were found in patients with full TS. 6, 12 Consistent with these reports, our patient had abnormally low metabolites in the temporal regions in two consecutive scans, performed 4 months apart, presumably reflecting subtle, persistent abnormalities in both mesial and lateral temporal lobe structures. Histopathological studies on patients with MRInegative epilepsy found discrete abnormalities, i.e. hippocampal sclerosis, microdysgenesis or focal cortical dysplasia, 19 indicating that epileptogenic lesions might be present with a normal MRI.
Reports on epilepsy in TS are extremely rare. Epilepsy is mostly described as symptomatic of developmental malformation seen on the MRI in some cases. 4, 5 One earlier EEG study showed epileptogenic activity in 1 of 64 TS patients, suggestive of idiopathic epilepsy, but without radiological documentation. 3 In a more recent study, no epileptiform activity was noted in 11 subjects with TS (2 with TSm). 2 However, the study type appeared to be of observational character, given that patients were recorded because of the presence of a chromosomal disorder. To the best of our knowledge, no study on the prevalence of chromosomal abnormalities in patients with pharmaco-resistant epilepsy has been done, thus we do not know how many patients seen in tertiary epilepsy centres present additional genetic abnormalities, including TSm.
The role of hormonal insufficiency (estrogens and androgens) appears to be relevant in many abnormal neurological, reproductive and neuropsychological conditions, including TS and also epilepsy. 20 While there was evidence for neurological and neuropsychological impairment, there was no indication of a reproductive disorder. Our patient has healthy children, and a gynecological and endocrinological work-up was normal, as can be seen in TSm and even in some full TS subjects. 21 There was no association between the seizure frequency and the menstrual cycle nor any modification induced by the progesterone-coated intra-uterine device. Therefore, there is no argument for a significant, direct hormonal influence on the bitemporal seizures in our patient; however, subtle changes exerting a non-cyclic effect cannot be ruled out.
The patient's twin sister, reportedly monozygotic, does not suffer from epilepsy. While we could not perform genetic testing in the sister, she should have a normal caryotype 46, XX without mosaicism, since the mosaic TS results from post-meiotic disturbances. Thus, the presence of the fertile and non-epileptic monozygotic twin does not speak against the association between epilepsy and mosaic TS.
Even if causality is difficult to ascertain based on a single case, this observation provides a valuable hypothesis for future diagnostic and therapeutic work-up. In our patient, only TS mosaicism has turned out to be a potentially relevant cause for epilepsy. Caryotype evaluation should be considered in cases of pharmaco-resistant temporal non-lesional epilepsy, also including patients with late epilepsy onset and no sign of gonadal dysfunction, in order to determine the frequency of this association.
